share_log

Needham Reiterates Buy on G1 Therapeutics, Maintains $12 Price Target

Moomoo 24/7 ·  Apr 12 06:00

Needham analyst Gil Blum reiterates G1 Therapeutics (NASDAQ:GTHX) with a Buy and maintains $12 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment